Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endeavor Study: Combination Therapy in Chronic Hepatitis B
NCT02360592Phase 4Completed
- Sponsor
- Tongji Hospital
- Start
- Jun 2013
- Primary completion
- Dec 2016
- Modality
- Split/Subunit Vaccines, Cytokines & Interferons, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of interferon alfa-2b, aldesleukin, Hepatitis B vaccine in Chronic Hepatitis B (CHB), sponsored by Tongji Hospital. Started Jun 2013; status: completed.
02
Drugs
interferon alfa-2baldesleukinHepatitis B vaccine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02360592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02360592.